Can a Team-Based approach curb alcohol use in liver disease?
NCT ID NCT05375682
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This pilot study tests whether a coordinated care program can help people with alcohol-related liver disease access addiction and mental health services more easily. The program brings together liver specialists, addiction medicine, and psychiatry to streamline referrals and care planning. Researchers will see if this approach is acceptable to patients and providers, and whether it helps reduce alcohol use and improve quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Integrated care program combining collaboration, streamlined referrals, and coordinated care conferences
- What this could lead to
- If successful, this integrated care approach could improve access to addiction services, reduce alcohol use, and enhance quality of life for people with alcohol-related liver disease.
- What could go wrong
- This is a small pilot study, so results may not be generalizable. The program's success depends on patient and provider engagement, and it may not lead to significant clinical improvements.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL-ASSOCIATED CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
John Buhler Centre
Winnipeg, Manitoba, R3E 3P4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.